Ca2+ signal-induced cardiomyocyte hypertrophy through activation of myocardin

Gene

Volumn 557, Issue 1, 2015, Pages 43-51

  Li, Man ^a   Wang, Nan ^a   Gong, Hui Qin ^a   Li, Wei Zong ^a   Liao, Xing Hua ^a,b   Yang, Xiao Long ^a   He, Hong Peng ^a   Cao, Dong Sun ^b   Zhang, Tong Cun ^a,b  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Ca2+ signals; Cardiomyocyte hypertrophy; Myocardin

Indexed keywords

ALPHA ACTININ; ATRIAL NATRIURETIC FACTOR; CALCIMYCIN; CALCIUM ION; EGTAZIC ACID; MYOCARDIN; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; SHORT HAIRPIN RNA; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; ACTIN; CALCINEURIN INHIBITOR; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHELATING AGENT; CALCIUM IONOPHORE; NUCLEAR PROTEIN; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL SIZE; CELL SURFACE; CHELATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE SILENCING; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; NEWBORN; NONHUMAN; PATHOGENESIS; PROMOTER REGION; RAT; SARCOMERE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CARDIOMEGALY; CELL LINE; CHEMISTRY; ENZYME ACTIVATION; GENETICS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; TRANSCRIPTION INITIATION;

RATTUS;

ACTINS; ANIMALS; ATRIAL NATRIURETIC FACTOR; CALCIMYCIN; CALCINEURIN INHIBITORS; CALCIUM; CALCIUM CHELATING AGENTS; CALCIUM IONOPHORES; CALCIUM SIGNALING; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOMEGALY; CELL LINE; EGTAZIC ACID; ENZYME ACTIVATION; MYOCYTES, CARDIAC; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, SMALL INTERFERING; SARCOMERES; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84920134158     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.12.007     Document Type: Article

References (24)

1. Akazawa H., Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Cardiovasc. Res. 2003, 92:1079-1088.
2. Cao D., Wang Z., Zhang C.L., Oh J., Xing W., Li S., Richardson J.A., et al. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol. Cell. Biol. 2005, 25:364-376.
3. 2+ signal integrators. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2859-2864.
4. Frey N., Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 2003, 65:45-79.
5. Frey N., McKinsey T.A., Olson E.N. Decoding calcium signals involved in cardiac growth and function. Nat. Med. 2000, 6:1221-1227.
6. 2+-induced PARP-1 activation and ANF expression are coupled events in cardiomyocytes. Biochem. J. 2011, 438:337-347.
7. 2+ signals contributes to angiotensin II-induced hypertrophy in adult rat cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H901-H909.
8. 2+ transients and arrhythmias associated with cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11406-11411.
9. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat. Rev. Mol. Cell Biol. 2006, 7:589-600.
10. 2+ release is a nexus for hypertrophic signaling in cardiac myocytes. Mol. Cell 2009, 33:472-482.
11. Hogan P.G., Chen L., Nardone J., Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003, 17:2205-2232.
12. Levy D., Anderson K.M., Savage D.D., Kannel W.B., Christiansen J.C., Castelli W.P. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. Ann. Intern. Med. 1988, 108:7-13.
13. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
14. 2+ signals that induce cardiac hypertrophy and heart failure. Circ. Res. 2008, 103:891-899.
15. Olson E.N., Schneider M.D. Sizing up the heart: development redux in disease. Genes Dev. 2003, 17:1937-1956.
16. 2+ entry in the cardiomyocyte. Circulation 2011, 124:766-768.
17. Tu V.C., Sun H., Bowden G.T., Chen Q.M. Involvement of oxidants and AP-1 in angiotensin II-activated NFAT3 transcription factor. Am. J. Physiol. Cell Physiol. 2007, 292:C1248-C1255.
18. 2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF dependent mechanism. Circ. Res. 2004, 95:406-414.
19. Wang K., Long B., Zhou J., Li P.F. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J. Biol. Chem. 2010, 285:11903-11912.
20. Xin H.B., Senbonmatsu T., Cheng D.S., Wang Y.X., Copello J.A., Ji G.J., Collier M.L., et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 2002, 416:334-338.
21. Xing W., Zhang T.C., Cao D., Wang Z., Antos C.L., Li S., Wang Y., et al. Myocardin induces cardiomyocyte hypertrophy. Circ. Res. 2006, 98:1089-1097.
22. Zhang X., Azhar G., Chai J., Sheridan P., Nagano K., Brown T., Yang J., et al. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H1782-H1792.
23. Zhang X., Chai J., Azhar G., Sheridan P., Borras A.M., Furr M.C., Khrapko K., et al. Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J. Biol. Chem. 2001, 276:40033-40040.
24. 2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J. Biol. Chem. 2000, 275:15239-15245.